Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD reports drug supply problems
The VMD has revealed that there are currently supply problems with a number of veterinary products. (Stock photo)
Directorate provides advice on alternative products 

The Veterinary Medicines Directorate (VMD) has revealed there are currently supply problems with a number of veterinary products, including leptospirosis vaccines for cattle and local anaesthetic products containing procaine hydrochloride.

Supply problems exist for the following products:

Vaccines for Leptospira hardjo and Leptospira borgpetersenii
There are supply issues with two leptospirosis vaccines authorised in the UK for use in cattle. Supply problems are expected to be resolved in October 2019. In the meantime, the VMD is accepting applications to import an EU alternative, BioBos L. injection suspension for cattle, which is licensed in the Czech Republic, and Spirovac, which is licensed in the USA.

Local anaesthetic products containing procaine hydrochloride
VMD said it is aware of UK availability issues with some of these products. Information on authorised products are available on the VMD’s product information database. Suppliers have advised that the UK authorised Pronestesic 40mg/ml / 0.036mg/ml Solution for Injection for Horses, Cattle, Pigs and Sheep, is available to meet present demand.

Viper Venom Antiserum for veterinary use (adder bite antivenom)
There are no viper venom antiserums licensed in the UK for treating adder bites in animals. VMD accepts applications to import European Viper Antiserum from Biomed (Poland) and the Institute of Immunology, Zagreb (Croatia). VMD said anyone wishing to import should contact the manufacturer before submitting an application to ensure they can supply the quantity needed.

In urgent cases, antivenom may be supplied, purchased and used prior to the special treatment certificate being obtained from the VMD.

ACP injection 10mg/ml solution for injection
This product is indicated for anaesthetic premedication, tranquillisation and sedation in horses. It is not known when stocks will be available. Applications are currently accepted to import this product for use in horses only. Two EU alternatives are available - Calmivet solution for injection (5mg/ml) and Vetranquil 1% solution for injection (10mg/ml).


For information on prescribing under the cascade, visit the VMD’s website.

Become a member or log in to add this story to your CPD history

RUMA CA&E extends survey deadline

News Story 1
 RUMA CA&E has extended the deadline for its online survey into vaccine availability.

Vets, SQPs, retailers and wholesalers will now have until Friday, 26 September at 5pm to submit their response.

The survey aims to further understanding into the vaccine supply challenges faced by the sector. It will also consider the short and long term impacts of disruption issues.

Insights are anonymous, and will be shared with industry stakeholders and government bodies.

The survey can be accessed here

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com